JP2015528468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528468A5 JP2015528468A5 JP2015530126A JP2015530126A JP2015528468A5 JP 2015528468 A5 JP2015528468 A5 JP 2015528468A5 JP 2015530126 A JP2015530126 A JP 2015530126A JP 2015530126 A JP2015530126 A JP 2015530126A JP 2015528468 A5 JP2015528468 A5 JP 2015528468A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- alkyl
- heterocyclyl
- carbocyclyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 34
- 239000001257 hydrogen Substances 0.000 claims 34
- 239000008194 pharmaceutical composition Substances 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 29
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 22
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- 229910052799 carbon Inorganic materials 0.000 claims 16
- 125000004432 carbon atom Chemical group C* 0.000 claims 13
- 125000005843 halogen group Chemical group 0.000 claims 13
- 208000015181 infectious disease Diseases 0.000 claims 13
- 229910052757 nitrogen Inorganic materials 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 125000004452 carbocyclyl group Chemical group 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 10
- 125000001424 substituent group Chemical group 0.000 claims 10
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000004429 atom Chemical group 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 3
- 241000202934 Mycoplasma pneumoniae Species 0.000 claims 3
- 206010057190 Respiratory tract infections Diseases 0.000 claims 3
- 241000193996 Streptococcus pyogenes Species 0.000 claims 3
- -1 fluoro compound Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 206010040872 skin infection Diseases 0.000 claims 3
- 241000894007 species Species 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 241001156739 Actinobacteria <phylum> Species 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 241001112696 Clostridia Species 0.000 claims 2
- 108010065152 Coagulase Proteins 0.000 claims 2
- 241000194032 Enterococcus faecalis Species 0.000 claims 2
- 241000194031 Enterococcus faecium Species 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000589242 Legionella pneumophila Species 0.000 claims 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims 2
- 241000186359 Mycobacterium Species 0.000 claims 2
- 241000295644 Staphylococcaceae Species 0.000 claims 2
- 241000193985 Streptococcus agalactiae Species 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229940115932 legionella pneumophila Drugs 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4s,4as,5ar,12ar)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O SOVUOXKZCCAWOJ-HJYUBDRYSA-N 0.000 claims 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- ITHCSGCUQDMYAI-ZMIZWQJLSA-N 2-carboxy-D-arabinitol 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@](O)(COP(O)(O)=O)C(O)=O ITHCSGCUQDMYAI-ZMIZWQJLSA-N 0.000 claims 1
- 241000589291 Acinetobacter Species 0.000 claims 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 1
- 241000304886 Bacilli Species 0.000 claims 1
- 241000606125 Bacteroides Species 0.000 claims 1
- 241000589968 Borrelia Species 0.000 claims 1
- 241000589876 Campylobacter Species 0.000 claims 1
- 241001185363 Chlamydiae Species 0.000 claims 1
- 241000498849 Chlamydiales Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 241000186216 Corynebacterium Species 0.000 claims 1
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 241000194033 Enterococcus Species 0.000 claims 1
- 241000589989 Helicobacter Species 0.000 claims 1
- 241000589248 Legionella Species 0.000 claims 1
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 1
- 241000186781 Listeria Species 0.000 claims 1
- 208000016604 Lyme disease Diseases 0.000 claims 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 1
- 241001430197 Mollicutes Species 0.000 claims 1
- 241000589289 Moraxellaceae Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 241000204031 Mycoplasma Species 0.000 claims 1
- 241000204003 Mycoplasmatales Species 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 241000606752 Pasteurellaceae Species 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 241000186429 Propionibacterium Species 0.000 claims 1
- 102100021486 Protein S100-G Human genes 0.000 claims 1
- 101710122252 Protein S100-G Proteins 0.000 claims 1
- 241000606651 Rickettsiales Species 0.000 claims 1
- 241000589973 Spirochaeta Species 0.000 claims 1
- 241000589970 Spirochaetales Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- 241000589886 Treponema Species 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 241000607493 Vibrionaceae Species 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940124307 fluoroquinolone Drugs 0.000 claims 1
- 229940041010 fourth-generation cephalosporins Drugs 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229960003085 meticillin Drugs 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims 1
- 229940041008 second-generation cephalosporins Drugs 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 229940072172 tetracycline antibiotic Drugs 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 229940041007 third-generation cephalosporins Drugs 0.000 claims 1
- 229960004089 tigecycline Drugs 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 claims 1
- 150000003952 β-lactams Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695947P | 2012-08-31 | 2012-08-31 | |
| US61/695,947 | 2012-08-31 | ||
| PCT/US2013/057690 WO2014036502A2 (en) | 2012-08-31 | 2013-08-30 | Tetracycline compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018034611A Division JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015528468A JP2015528468A (ja) | 2015-09-28 |
| JP2015528468A5 true JP2015528468A5 (enExample) | 2016-10-13 |
| JP6301335B2 JP6301335B2 (ja) | 2018-03-28 |
Family
ID=49170898
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015530126A Active JP6301335B2 (ja) | 2012-08-31 | 2013-08-30 | テトラサイクリン化合物 |
| JP2018034611A Active JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018034611A Active JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US9573895B2 (enExample) |
| EP (2) | EP2890673B1 (enExample) |
| JP (2) | JP6301335B2 (enExample) |
| KR (2) | KR102375238B1 (enExample) |
| CN (3) | CN108276404A (enExample) |
| AU (3) | AU2013308504B2 (enExample) |
| BR (1) | BR112015004523B1 (enExample) |
| CA (1) | CA2883238C (enExample) |
| CY (1) | CY1122744T1 (enExample) |
| DK (1) | DK2890673T3 (enExample) |
| EA (2) | EA036088B1 (enExample) |
| ES (1) | ES2712476T3 (enExample) |
| HR (1) | HRP20190268T1 (enExample) |
| HU (1) | HUE042600T2 (enExample) |
| IL (2) | IL237437B (enExample) |
| LT (1) | LT2890673T (enExample) |
| ME (1) | ME03329B (enExample) |
| MX (2) | MX364400B (enExample) |
| NZ (3) | NZ705849A (enExample) |
| PL (1) | PL2890673T3 (enExample) |
| PT (1) | PT2890673T (enExample) |
| RS (1) | RS58572B1 (enExample) |
| SG (2) | SG11201501516YA (enExample) |
| SI (1) | SI2890673T1 (enExample) |
| SM (1) | SMT201900096T1 (enExample) |
| TR (1) | TR201902057T4 (enExample) |
| WO (1) | WO2014036502A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE026562T2 (hu) | 2008-08-08 | 2016-06-28 | Tetraphase Pharmaceuticals Inc | C7-fluor-helyettesített tetraciklin vegyületek |
| CN102459153A (zh) | 2009-05-08 | 2012-05-16 | 四相制药公司 | 四环素类化合物 |
| EP2470500B1 (en) | 2009-08-28 | 2017-10-04 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| TR201902057T4 (tr) * | 2012-08-31 | 2019-03-21 | Tetraphase Pharmaceuticals Inc | Tetrasiklin bileşikleri. |
| MA46102A (fr) * | 2016-08-30 | 2019-07-10 | Tetraphase Pharmaceuticals Inc | Composés de tétracycline et méthodes de traitement |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
| WO2020020999A1 (en) | 2018-07-27 | 2020-01-30 | Sandoz Ag | Process for preparing rapidly or very rapidly dissolving tablets comprising freely soluble api |
| CN113444070A (zh) * | 2021-07-28 | 2021-09-28 | 深圳市真味生物科技有限公司 | 一种由手性叔丁基亚磺酰胺合成手性尼古丁的制备方法 |
| CN115448849B (zh) * | 2022-11-10 | 2023-02-03 | 苏州富士莱医药股份有限公司 | 一种2-苄氧基-3-二苄基氨基-5-氟-6-甲基苯甲酸苯酯的制备方法 |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE639292A (enExample) | ||||
| GB935384A (en) * | 1959-03-30 | 1963-08-28 | Pfizer & Co C | Tetracycline derivatives and preparation thereof |
| US3338963A (en) | 1960-10-28 | 1967-08-29 | American Cyanamid Co | Tetracycline compounds |
| GB1034933A (en) * | 1962-10-29 | 1966-07-06 | American Cyanamid Co | 4-demethylamino-4-substituted amino 6-demethyl tetracyclines |
| US3364123A (en) * | 1963-05-06 | 1968-01-16 | Squibb & Sons Inc | Production of 4n-demethyl-4n-ethyl tetracyclines |
| USRE26253E (en) | 1963-05-17 | 1967-08-15 | And z-alkylamino-g-deoxytetracycline | |
| GB1065715A (en) * | 1964-04-16 | 1967-04-19 | Pfizer & Co C | Tetracycline derivatives |
| US3247226A (en) * | 1964-07-06 | 1966-04-19 | American Cyanamid Co | 4-dimethylamino and 4-hydroxytetracycloxides |
| US3394178A (en) * | 1965-01-26 | 1968-07-23 | Merck & Co Inc | Nu-ethyloxytetracycline |
| GB1077598A (en) | 1965-05-12 | 1967-08-02 | Pfizer & Co C | Preparation of n-demethyl tetracyclines |
| US3304227A (en) | 1965-07-15 | 1967-02-14 | Loyal E Loveless | Antibiotic-containing animal feed |
| US3433709A (en) | 1965-12-07 | 1969-03-18 | American Cyanamid Co | Biological transformation of alpha-6-deoxytetracyclines to tetracyclines |
| US3849493A (en) * | 1966-08-01 | 1974-11-19 | Pfizer | D-ring substituted 6-deoxytetracyclines |
| US3824285A (en) * | 1967-09-13 | 1974-07-16 | Pfizer | 4-oxo-4-dedimethylaminotetracycline-4,6-hemiketals |
| US3947517A (en) | 1969-06-12 | 1976-03-30 | Research Corporation | Stereoselective introduction of tetracyclines hydroxyl group at 12(a) position in synthesis of tetracyclines |
| DE2437487A1 (de) | 1974-08-03 | 1976-02-19 | Merck Patent Gmbh | 7-methoxy-6-thia-tetracycline und verfahren zu ihrer herstellung |
| DE2442829A1 (de) * | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
| YU290176A (en) | 1976-11-26 | 1982-05-31 | Pliva Zagreb | Process for preparing 4-dedimethylamino-4-arylsulfonamido-5a,6-anhydrotetracycline |
| US4935412A (en) | 1983-12-29 | 1990-06-19 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| USRE34656E (en) | 1983-12-29 | 1994-07-05 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency |
| US4666897A (en) | 1983-12-29 | 1987-05-19 | Research Foundation Of State University | Inhibition of mammalian collagenolytic enzymes by tetracyclines |
| US4704383A (en) | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| US4925833A (en) | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| JP3016587B2 (ja) | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
| US5308839A (en) | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| US5770588A (en) | 1991-02-11 | 1998-06-23 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions of the prevention and treatment of root caries |
| US5231017A (en) | 1991-05-17 | 1993-07-27 | Solvay Enzymes, Inc. | Process for producing ethanol |
| DK0536515T3 (da) | 1991-10-04 | 2002-04-08 | American Cyanamid Co | Nye 7-substitueret-9-substitueret amino-6-demethyl-6-deoxytetracycliner |
| USRE40183E1 (en) | 1991-10-04 | 2008-03-25 | Wyeth Holdings Corporation | 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| US5494903A (en) | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| US5258371A (en) | 1992-05-29 | 1993-11-02 | Kuraray Co., Ltd. | Method to reduce connective tissue destruction |
| US6043225A (en) | 1992-06-12 | 2000-03-28 | Board Of Regents Of The University Of Washington | Diagnosis and treatment of arterial chlamydial granuloma |
| SG47520A1 (en) | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
| US5420272A (en) | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| US5284963A (en) | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
| US5328902A (en) | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| US5442059A (en) | 1992-08-13 | 1995-08-15 | American Cyanamid Company | 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines |
| JPH06256280A (ja) | 1992-11-17 | 1994-09-13 | Univ New York State | 糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン |
| US6043231A (en) | 1993-03-02 | 2000-03-28 | The Research Foundation Of State Univ. Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
| US5523297A (en) | 1993-03-02 | 1996-06-04 | The Research Foundation Of State University Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
| US5371076A (en) | 1993-04-02 | 1994-12-06 | American Cyanamid Company | 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| US5668122A (en) | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
| WO1995022529A1 (en) | 1994-02-17 | 1995-08-24 | Pfizer Inc. | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
| US5843925A (en) | 1994-12-13 | 1998-12-01 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
| US5574026A (en) | 1994-12-13 | 1996-11-12 | American Cyanamid Company | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth |
| US5834449A (en) | 1996-06-13 | 1998-11-10 | The Research Foundation Of State University Of New York | Treatment of aortic and vascular aneurysms with tetracycline compounds |
| US5827840A (en) | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
| US5789395A (en) | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| US5919774A (en) | 1996-12-10 | 1999-07-06 | Eli Lilly And Company | Pyrroles as sPLA2 inhibitors |
| US5837696A (en) | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
| US5773430A (en) | 1997-03-13 | 1998-06-30 | Research Foundation Of State University Of New York | Serine proteinase inhibitory activity by hydrophobic tetracycline |
| US5929055A (en) | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
| AU753370B2 (en) | 1998-01-23 | 2002-10-17 | Trustees Of Tufts College | Pharmaceutically active compounds and methods of use thereof |
| US6277061B1 (en) | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
| US6015804A (en) | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
| US5977091A (en) | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
| US6914057B1 (en) | 1998-09-28 | 2005-07-05 | The Research Foundation Of State University Of New York | Inhibitor of cataract formation |
| US5998390A (en) | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
| EP1124558A4 (en) | 1998-09-28 | 2004-10-27 | Res Foundation Ofstate Univers | NEW INHIBITANT AGAINST CATARACT EDUCATION |
| US6231894B1 (en) | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| AU2000257445A1 (en) | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-n-substituted phenyl tetracycline compounds |
| CZ2003344A3 (cs) | 2000-07-07 | 2003-05-14 | Trustees Of Tufts College | 9-Substituované minocyklinové sloučeniny |
| ATE504562T1 (de) | 2000-07-07 | 2011-04-15 | Tufts College | 7-, 8- und 9-substitutierte tetracyclinverbindungen |
| BR0112265A (pt) | 2000-07-07 | 2003-06-24 | Tufts College | Compostos de tetraciclina substituìda, e de sanciclina 7-substituìda, método para tratar um estado responsivo à tetraciclina em um indivìduo, e, composição farmacêutica |
| WO2002072532A1 (en) | 2001-03-13 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | 7, 9-substituted tetracycline compounds |
| EP1381372A2 (en) | 2001-03-14 | 2004-01-21 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as synergistic antifungal agents |
| US6841546B2 (en) | 2001-03-14 | 2005-01-11 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
| EP1399414B1 (en) | 2001-04-24 | 2010-01-13 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| US8088820B2 (en) | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| US20060194773A1 (en) | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
| EP1408987B1 (en) | 2001-07-13 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
| EP2311797A1 (en) | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| JP2005526754A (ja) | 2002-03-08 | 2005-09-08 | パラテック ファーマシューティカルズ インコーポレイテッド | アミノメチル置換されたテトラサイクリン化合物 |
| EP1503981A4 (en) | 2002-03-21 | 2007-08-15 | Paratek Pharm Innc | SUBSTITUTED TETRACYCLINE COMPOUNDS |
| WO2004006850A2 (en) | 2002-07-12 | 2004-01-22 | Paratek Pharmaceuticals, Inc | 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| WO2004038001A2 (en) | 2002-10-24 | 2004-05-06 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| JP4686189B2 (ja) | 2002-10-24 | 2011-05-18 | パラテック ファーマシューティカルズ インコーポレイテッド | Ｒｎａを調節するための置換テトラサイクリン化合物の使用方法 |
| WO2005009943A2 (en) | 2003-07-09 | 2005-02-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| WO2005082860A1 (en) | 2004-02-27 | 2005-09-09 | National Research Council Of Canada | Tetracyclines and their use as calpain inhibitors |
| KR101171408B1 (ko) | 2004-05-21 | 2012-08-08 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 테트라사이클린 및 이의 유사체의 합성 |
| JP2008518025A (ja) * | 2004-10-25 | 2008-05-29 | パラテック ファーマシューティカルズ インコーポレイテッド | ４−アミノテトラサイクリンおよびその使用の方法 |
| WO2006047756A2 (en) | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| AU2006210406C1 (en) | 2005-02-04 | 2013-03-07 | Paratek Pharmaceuticals, Inc. | 11a, 12-derivatives of tetracycline compounds |
| CN101119964A (zh) | 2005-02-15 | 2008-02-06 | 惠氏公司 | 9-经取代四环素 |
| CA2616224A1 (en) | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
| EP1991236A2 (en) | 2006-01-24 | 2008-11-19 | Paratek Pharmaceuticals, Inc. | Methods of increasing oral bioavailability of tetracyclines |
| JP5335664B2 (ja) * | 2006-04-07 | 2013-11-06 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | テトラサイクリンおよびその類似体の合成 |
| WO2007133797A2 (en) | 2006-05-15 | 2007-11-22 | Paratek Pharmaceuticals, Inc. | Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| WO2008045507A2 (en) | 2006-10-11 | 2008-04-17 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| EP2479169B1 (en) | 2006-10-11 | 2014-12-03 | President and Fellows of Harvard College | Synthesis of Enone Intermediate |
| IL270446B2 (en) | 2006-12-21 | 2023-10-01 | Paratek Pharm Innc | A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition |
| TWI334106B (en) | 2006-12-27 | 2010-12-01 | Icp Electronics Inc | Apparatus for converting gray scale and method for the same |
| EP2144614A1 (en) | 2007-04-12 | 2010-01-20 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
| WO2009009042A1 (en) | 2007-07-06 | 2009-01-15 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing substituted tetracycline compounds |
| WO2009073056A1 (en) | 2007-09-07 | 2009-06-11 | Dr. Reddy's Laboratories Ltd. | Novel tetracycline derivatives as antibacterial agents |
| JP2011517697A (ja) | 2008-04-14 | 2011-06-16 | パラテック ファーマシューティカルズ インコーポレイテッド | 置換テトラサイクリン化合物 |
| US8338477B2 (en) * | 2008-07-11 | 2012-12-25 | Neumedics | Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| HUE026562T2 (hu) | 2008-08-08 | 2016-06-28 | Tetraphase Pharmaceuticals Inc | C7-fluor-helyettesített tetraciklin vegyületek |
| WO2010126607A2 (en) | 2009-04-30 | 2010-11-04 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
| US8367654B2 (en) | 2009-05-08 | 2013-02-05 | Tetraphase Pharmaceuticals, Inc. | 8-AZA tetracycline compounds |
| CN102459153A (zh) | 2009-05-08 | 2012-05-16 | 四相制药公司 | 四环素类化合物 |
| US20120115819A1 (en) | 2009-05-13 | 2012-05-10 | Clark Roger B | Pentacycline Compounds |
| EP2470500B1 (en) | 2009-08-28 | 2017-10-04 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| US20120329761A1 (en) | 2010-03-10 | 2012-12-27 | University Health Network | Use of tigecycline for treatment of cancer |
| WO2011123536A1 (en) | 2010-03-31 | 2011-10-06 | Tetraphase Pharmaceuticals, Inc. | Polycyclic tetracycline compounds |
| WO2012021712A1 (en) * | 2010-08-12 | 2012-02-16 | Tetraphase Pharmaceuticals, Inc. | Tetracycline analogs |
| WO2012047907A1 (en) | 2010-10-04 | 2012-04-12 | President And Fellows Of Harvard College | Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto |
| TR201902057T4 (tr) | 2012-08-31 | 2019-03-21 | Tetraphase Pharmaceuticals Inc | Tetrasiklin bileşikleri. |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
| WO2017125557A1 (en) | 2016-01-22 | 2017-07-27 | Sandoz Ag | Crystalline eravacycline bis-hydrochloride |
| MA46102A (fr) | 2016-08-30 | 2019-07-10 | Tetraphase Pharmaceuticals Inc | Composés de tétracycline et méthodes de traitement |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
-
2013
- 2013-08-30 TR TR2019/02057T patent/TR201902057T4/tr unknown
- 2013-08-30 CA CA2883238A patent/CA2883238C/en active Active
- 2013-08-30 ME MEP-2019-48A patent/ME03329B/me unknown
- 2013-08-30 PL PL13762660T patent/PL2890673T3/pl unknown
- 2013-08-30 EP EP13762660.2A patent/EP2890673B1/en active Active
- 2013-08-30 KR KR1020217026972A patent/KR102375238B1/ko active Active
- 2013-08-30 PT PT13762660T patent/PT2890673T/pt unknown
- 2013-08-30 KR KR1020157008309A patent/KR102295673B1/ko not_active Expired - Fee Related
- 2013-08-30 EA EA201891804A patent/EA036088B1/ru unknown
- 2013-08-30 NZ NZ705849A patent/NZ705849A/en not_active IP Right Cessation
- 2013-08-30 HR HRP20190268TT patent/HRP20190268T1/hr unknown
- 2013-08-30 MX MX2015002657A patent/MX364400B/es active IP Right Grant
- 2013-08-30 JP JP2015530126A patent/JP6301335B2/ja active Active
- 2013-08-30 LT LTEP13762660.2T patent/LT2890673T/lt unknown
- 2013-08-30 EA EA201590475A patent/EA031523B1/ru unknown
- 2013-08-30 ES ES13762660T patent/ES2712476T3/es active Active
- 2013-08-30 CN CN201810192454.1A patent/CN108276404A/zh active Pending
- 2013-08-30 MX MX2019004452A patent/MX390763B/es unknown
- 2013-08-30 SI SI201331346T patent/SI2890673T1/sl unknown
- 2013-08-30 SG SG11201501516YA patent/SG11201501516YA/en unknown
- 2013-08-30 DK DK13762660.2T patent/DK2890673T3/en active
- 2013-08-30 US US14/424,765 patent/US9573895B2/en active Active
- 2013-08-30 CN CN201380056726.0A patent/CN104768922B/zh active Active
- 2013-08-30 SG SG10201801703RA patent/SG10201801703RA/en unknown
- 2013-08-30 HU HUE13762660A patent/HUE042600T2/hu unknown
- 2013-08-30 NZ NZ74005113A patent/NZ740051A/en not_active IP Right Cessation
- 2013-08-30 RS RS20190195A patent/RS58572B1/sr unknown
- 2013-08-30 AU AU2013308504A patent/AU2013308504B2/en active Active
- 2013-08-30 NZ NZ74559613A patent/NZ745596A/en not_active IP Right Cessation
- 2013-08-30 EP EP18192684.1A patent/EP3461809B1/en active Active
- 2013-08-30 SM SM20190096T patent/SMT201900096T1/it unknown
- 2013-08-30 BR BR112015004523-5A patent/BR112015004523B1/pt active IP Right Grant
- 2013-08-30 WO PCT/US2013/057690 patent/WO2014036502A2/en not_active Ceased
- 2013-08-30 CN CN201810192506.5A patent/CN108329312B/zh not_active Expired - Fee Related
-
2015
- 2015-02-26 IL IL237437A patent/IL237437B/en not_active IP Right Cessation
-
2016
- 2016-10-18 AU AU2016247054A patent/AU2016247054B2/en not_active Ceased
-
2017
- 2017-01-06 US US15/400,674 patent/US10315992B2/en active Active
- 2017-02-08 AU AU2017200857A patent/AU2017200857B2/en active Active
-
2018
- 2018-02-28 JP JP2018034611A patent/JP6691157B2/ja active Active
-
2019
- 2019-02-14 CY CY20191100197T patent/CY1122744T1/el unknown
- 2019-04-24 US US16/393,725 patent/US10913712B2/en active Active
- 2019-05-19 IL IL266719A patent/IL266719A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523761A5 (enExample) | ||
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| SA520411571B1 (ar) | مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية | |
| JP2011530534A5 (enExample) | ||
| HRP20210484T1 (hr) | Antimikrobna sredstva koja se temelje na imidazolu | |
| PH12022551444A1 (en) | Novel compounds and their use | |
| RU2013137752A (ru) | Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины | |
| JP2020536966A5 (enExample) | ||
| JP2016503778A5 (enExample) | ||
| JP2018524406A5 (enExample) | ||
| PH12018500202A1 (en) | New effective aminoglycoside antibiotic for multidrug-resistant | |
| Flamm et al. | Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011) | |
| MX385203B (es) | Compuestos y métodos para tratar infecciones bacterianas. | |
| GEP20247641B (en) | Oxazolidinone compound and methods of use thereof as an antibacterial agent | |
| PE20181143A1 (es) | Compuestos para uso en aplicaciones antibacterianas | |
| JP2010507576A5 (enExample) | ||
| CY1124577T1 (el) | Καινοτομες ενωσεις τετραζολιου και η χρηση τους στη θεραπεια της φυματιωσης | |
| JP2024009968A5 (enExample) | ||
| RU2004117082A (ru) | Кетолидные 6-0-ацил-производные эритромицина в качестве антибактериальных средств | |
| WO2009001192A3 (en) | Novel compounds and their use | |
| EA201590876A1 (ru) | Спироизоксазолиновые соединения, обладающие активностью, усиливающей активность антибиотика | |
| JP2021516680A5 (enExample) | ||
| JP2008543964A5 (enExample) | ||
| JP2008546825A5 (enExample) |